SCHEMBL4812926

SCHEMBL4812926

CCCCC/C=C\CC1CC1CCCCCCCC(=O)OC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.54
ALOX5 P09917 4/20 0.48
CNR2 P34972 3/20 0.47
CNR1 P21554 2/20 0.47
TRPV1 Q8NER1 2/20 0.47
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
HKDC1 Q2TB90 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
SAE1 Q9UBE0 1/20 0.47
UBA2 Q9UBT2 1/20 0.47
OXER1 Q8TDS5 1/20 0.46
PGR P06401 1/20 0.45
ADORA3 P0DMS8 1/20 0.45
ADRA2C P18825 1/20 0.45
SLC6A2 P23975 1/20 0.45
HTR2B P41595 1/20 0.45
MC3R P41968 1/20 0.45
SLC6A3 Q01959 1/20 0.45
PDE4D Q08499 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4812943 1.00 EPHX2 (0.54) EPHX2ALOX5CNR2CNR1TRPV1
SCHEMBL2505318 0.86 ALOX5 (0.62) EPHX2ALOX5CNR2CNR1TRPV1
SCHEMBL31039608 0.86 ALOX5 (0.62) EPHX2ALOX5CNR2CNR1TRPV1
SCHEMBL2508700 0.86 ALOX5 (0.62) EPHX2ALOX5CNR2CNR1TRPV1
SCHEMBL2508699 0.86 ALOX5 (0.62) EPHX2ALOX5CNR2CNR1TRPV1
SCHEMBL10085305 0.86 ALOX5 (0.62) EPHX2ALOX5CNR2CNR1TRPV1
SCHEMBL2505317 0.86 ALOX5 (0.62) EPHX2ALOX5CNR2CNR1TRPV1
SCHEMBL16174233 0.86 ALOX5 (0.62) EPHX2ALOX5CNR2CNR1TRPV1
SCHEMBL4804331 0.85 ALOX5 (0.68) ALOX5KDM4EALDH1A1TDP1OXER1
SCHEMBL21173235 0.85 ALOX5 (0.51) ALOX5CNR2CNR1TRPV1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7468389-B2 Carboxylic acid compound having cyclopropane ring TOX K.K. (JP) 2008-12-23 US disclosed
EP-1343746-B1 USE OF CARBOXYLIC ACID COMPOUND HAVING CYCLOPROPANE RING AS MEDICAMENT TOX KK (JP) 2006-06-14 EP disclosed
US-20050075393-A1 Carboxylic acid compound cyclopropane ring NISHIZAKI BIOINFORMATION RESEARCH INSTITUTE (JP) 2005-04-07 US disclosed
EP-1343746-A1 CARBOXYLIC ACID COMPOUND HAVING CYCLOPROPANE RING FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-09-17 EP disclosed
WO-2002050013-A1 CARBOXYLIC ACID COMPOUND HAVING CYCLOPROPANE RING FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-06-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050075393-A1 Carboxylic acid compound cyclopropane ring SLC1A2, GRIN1, BDNF EPHX2 997/4885ALOX5 287/4885CNR2 79/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.